Marshall Wace’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Sell |
529,211
-111,706
| -17% | -$5.27M | 0.03% | 454 |
|
|
2025
Q1 | $25M | Sell |
640,917
-604,382
| -49% | -$23.6M | 0.03% | 423 |
|
|
2024
Q4 | $67.4M | Buy |
1,245,299
+90,914
| +8% | +$4.92M | 0.08% | 210 |
|
|
2024
Q3 | $58.2M | Buy |
1,154,385
+55,755
| +5% | +$2.81M | 0.07% | 225 |
|
|
2024
Q2 | $48.3M | Buy |
1,098,630
+587,684
| +115% | +$25.8M | 0.06% | 255 |
|
|
2024
Q1 | $25.7M | Buy |
+510,946
| New | +$25.7M | 0.04% | 375 |
|
|
2023
Q4 | – | Sell |
-30,451
| Closed | -$1.74M | – | 2120 |
|
|
2023
Q3 | $1.74M | Sell |
30,451
-27,932
| -48% | -$1.59M | ﹤0.01% | 1097 |
|
|
2023
Q2 | $2.98M | Buy |
+58,383
| New | +$2.98M | 0.01% | 1014 |
|
|
2022
Q2 | – | Sell |
-653,872
| Closed | -$7.26M | – | 2986 |
|
|
2022
Q1 | $7.26M | Buy |
653,872
+120,968
| +23% | +$1.34M | 0.01% | 1030 |
|
|
2021
Q4 | $5.27M | Buy |
+532,904
| New | +$5.27M | 0.01% | 1166 |
|